Par Nijhawan is the founder of Edesa Biotech. He has served in this role since forming the company in 2015. Based in Greater Toronto Area, Canada.
Par Nijhawan is the founder and CEO of Edesa Biotech, a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases. He has served in this role since forming the company in 2015. Edesa Biotech's clinical pipeline is focused on medical dermatology and respiratory. Prior to Edesa, Nijhawan founded Medical Futures Inc., which was sold to Tribute Pharmaceuticals, and Exzell Pharma, which was sold to BioLab Pharma in 2022.
Full founder directory · Investor directory · Company funding database · Fundraising library